Multi-center, Single Arm Phase II Study of Myeloablative Allogeneic Stem Cell Transplantation for Non-Remission Acute Myeloblastic Leukemia (AML) using Clofarabine and Busulfan x 4 (CloBu4) Regimen

Grant

Date/time Interval

  • July 1, 2012 - January 31, 2016
  • Awarded By

    Total Award Amount

  • 40600.00
  • Direct Costs

  • 32222.00
  • Sponsor Award Id

  • Contributor

  • Donna Salzman M.D.   Investigator  
  • Racquel Innis-Shelton M.D.   Investigator  
  • William Vaughan   Investigator